From Casetext: Smarter Legal Research

Warner Chilcott Co. v. Impax Labs., Inc.

United States Court of Appeals for the Federal Circuit
May 24, 2012
2012-1376 (Fed. Cir. May. 24, 2012)

Opinion

2012-1376 2012-1377 2012-1378

05-24-2012

WARNER CHILCOTT COMPANY, LLC, WARNER CHILCOTT (US), LLC, and MAYNE PHARMA INTERNATIONAL PTY. LTD., Plaintiffs-Appellants, v. IMPAX LABORATORIES, INC., Defendant-Appellee, AND MYLAN PHARMACEUTICALS INC. and MYLAN INC., Defendants-Appellees, AND SANDOZ, INC., Defendant-Appellee.


NOTE: This order is nonprecedential.

Appeals from the United States District Court for the District of New Jersey in consolidated case nos. 08-CV-6304, 09-CV-1233, and 09-CV-2073, Judge William J. Martini.

ON MOTION

Before NEWMAN, Circuit Judge.


ORDER

Warner Chilcott Company, LLC, Warner Chilcott (US), LLC, and Mayne Pharma International Pty. Ltd. move to expedite the briefing schedule and oral argument in these appeals. Impax Laboratories, Inc., Mylan Pharmaceuticals Inc. and Mylan Inc. oppose.

Upon consideration thereof,

IT IS ORDERED THAT:

The motion is granted. Warner Chilcott's brief is due on June 8, 2012. Impax and Mylan and Sandoz, Inc.'s briefs are due on July 13, 2012. Warner Chilcott's reply brief and the joint appendix are due on July 25, 2012. Oral argument will be scheduled by subsequent order.

FOR THE COURT

________________

Jan Horbaly

Clerk

cc: Dominick A. Conde, Esq.

Michael E. Patunas, Esq.

Larry L. Shatzer, III, Esq

Eric I. Abraham, Esq.

s23


Summaries of

Warner Chilcott Co. v. Impax Labs., Inc.

United States Court of Appeals for the Federal Circuit
May 24, 2012
2012-1376 (Fed. Cir. May. 24, 2012)
Case details for

Warner Chilcott Co. v. Impax Labs., Inc.

Case Details

Full title:WARNER CHILCOTT COMPANY, LLC, WARNER CHILCOTT (US), LLC, and MAYNE PHARMA…

Court:United States Court of Appeals for the Federal Circuit

Date published: May 24, 2012

Citations

2012-1376 (Fed. Cir. May. 24, 2012)